Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Glutamic-acid | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Glutamic-acid | hsa00100 | Steroid biosynthesis | 4.70E-02 | 1 | P35610 | SOAT1 | More | | Glutamic-acid | hsa00220 | Arginine biosynthesis | 1.58E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Glutamic-acid | hsa00230 | Purine metabolism | 1.82E-02 | 1 | P49915 | GMPS | More | | Glutamic-acid | hsa00250 | Alanine, aspartate and glutamate metabolism | 3.58E-02 | 2 | Q96RQ9, P15104 | IL4I1, GLUL | More | | Glutamic-acid | hsa00280 | Valine, leucine and isoleucine degradation | 4.31E-02 | 2 | P26440, Q02252 | IVD, ALDH6A1 | More | | Glutamic-acid | hsa00310 | Lysine degradation | 1.53E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Glutamic-acid | hsa00330 | Arginine and proline metabolism | 3.77E-02 | 1 | P54886 | ALDH18A1 | More | | Glutamic-acid | hsa00410 | beta-Alanine metabolism | 4.50E-02 | 1 | Q6ZQY3 | GADL1 | More | | Glutamic-acid | hsa00471 | D-Glutamine and D-glutamate metabolism | 2.28E-02 | 1 | Q7Z3D6 | C14orf159 | More | | Glutamic-acid | hsa00480 | Glutathione metabolism | 3.02E-02 | 1 | P48506 | GCLC | More | | Glutamic-acid | hsa00500 | Starch and sucrose metabolism | 1.13E-03 | 3 | O43451, P46976, P35557 | MGAM, GYG1, GCK | More | | Glutamic-acid | hsa00512 | Mucin type O-glycan biosynthesis | 1.22E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Glutamic-acid | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 4.70E-02 | 1 | P35557 | GCK | More | | Glutamic-acid | hsa00562 | Inositol phosphate metabolism | 2.54E-03 | 4 | P27987, Q13572, Q96PE3, P42338 | ITPKB, ITPK1, INPP4A, PIK3CB | More | | Glutamic-acid | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 4.50E-02 | 1 | Q14442 | PIGH | More | | Glutamic-acid | hsa00564 | Glycerophospholipid metabolism | 1.97E-02 | 3 | P48651, Q9Y6K0, P35790 | PTDSS1, CEPT1, CHKA | More | | Glutamic-acid | hsa00565 | Ether lipid metabolism | 3.21E-03 | 1 | Q8N661 | TMEM86B | More | | Glutamic-acid | hsa00670 | One carbon pool by folate | 1.14E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Glutamic-acid | hsa00730 | Thiamine metabolism | 1.75E-04 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Glutamic-acid | hsa00770 | Pantothenate and CoA biosynthesis | 6.41E-04 | 3 | O95498, O95497, Q6ZQY3 | VNN2, VNN1, GADL1 | More | | Glutamic-acid | hsa00860 | Porphyrin and chlorophyll metabolism | 1.05E-04 | 3 | P36551, P53004, P30043 | CPOX, BLVRA, BLVRB | More | | Glutamic-acid | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.58E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Glutamic-acid | hsa00983 | Drug metabolism - other enzymes | 6.63E-03 | 1 | P49915 | GMPS | More | | Glutamic-acid | hsa01240 | Biosynthesis of cofactors | 3.34E-02 | 3 | P05186, Q9Y6K8, O75911 | ALPL, AK5, DHRS3 | More | | Glutamic-acid | hsa01523 | Antifolate resistance | 3.80E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Glutamic-acid | hsa02010 | ABC transporters | 7.05E-03 | 2 | Q8IZY2, Q99758 | ABCA7, ABCA3 | More | | Glutamic-acid | hsa03010 | Ribosome | 1.22E-02 | 2 | P46777, P50914 | RPL5, RPL14 | More | | Glutamic-acid | hsa03018 | RNA degradation | 3.02E-02 | 1 | Q13901 | C1D | More | | Glutamic-acid | hsa03040 | Spliceosome | 2.10E-07 | 17 | Q14562, O43143, O60508, O14776, P08579, P26368, P09651, Q15365, O75494, Q13595, Q01130, Q13243, Q16629, P11142, Q9Y2W2, O43447, P61326 | DHX8, DHX15, CDC40, TCERG1, SNRPB2, U2AF2, HNRNPA1, PCBP1, FUSIP1, TRA2A, SFRS2, SFRS5, SFRS7, HSPA8, WBP11, PPIH, MAGOH | More | | Glutamic-acid | hsa03060 | Protein export | 4.36E-02 | 1 | Q15005 | SPCS2 | More | | Glutamic-acid | hsa03430 | Mismatch repair | 3.12E-02 | 3 | P43246, Q15054, Q04837 | MSH2, POLD3, SSBP1 | More | | Glutamic-acid | hsa03450 | Non-homologous end-joining | 3.27E-03 | 2 | Q9NP87, P13010 | POLM, XRCC5 | More | | Glutamic-acid | hsa04014 | Ras signaling pathway | 3.62E-02 | 5 | P42338, P49767, P0DP23, P63218, P50151 | PIK3CB, VEGFC, CALM1, GNG5, GNG10 | More | | Glutamic-acid | hsa04020 | Calcium signaling pathway | 5.15E-05 | 8 | P27987, P21796, Q16566, P30679, O15399, P0DP23, P23634, P49767 | ITPKB, VDAC1, CAMK4, GNA15, GRIN2D, CALM1, ATP2B4, VEGFC | More | | Glutamic-acid | hsa04024 | cAMP signaling pathway | 2.46E-03 | 6 | P42338, P0DP23, P23634, Q16566, Q09472, O15399 | PIK3CB, CALM1, ATP2B4, CAMK4, EP300, GRIN2D | More | | Glutamic-acid | hsa04062 | Chemokine signaling pathway | 1.81E-02 | 3 | P10145, P09769, Q13009 | IL8, FGR, TIAM1 | More | | Glutamic-acid | hsa04064 | NF-kappa B signaling pathway | 3.86E-02 | 5 | O00463, Q13077, P06239, P24522, P09341 | TRAF5, TRAF1, LCK, GADD45A, CXCL1 | More | | Glutamic-acid | hsa04070 | Phosphatidylinositol signaling system | 1.49E-03 | 5 | P0DP23, P42338, Q96PE3, Q13572, P27987 | CALM1, PIK3CB, INPP4A, ITPK1, ITPKB | More | | Glutamic-acid | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2 | EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2 | More | | Glutamic-acid | hsa04080 | Neuroactive ligand-receptor interaction | 2.60E-02 | 2 | P00734, Q96G91 | F2, P2RY11 | More | | Glutamic-acid | hsa04110 | Cell cycle | 6.80E-03 | 6 | P06493, O75293, P30304, P33981, P42773, P01106 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | | Glutamic-acid | hsa04145 | Phagosome | 4.44E-02 | 3 | P60709, P63261, P30511 | ACTB, ACTG1, HLA-F | More | | Glutamic-acid | hsa04151 | PI3K-Akt signaling pathway | 6.25E-03 | 17 | P42338, P21860, P43657, P07900, P08238, P63218, P50151, P61952, P23229, O15335, Q13751, P48551, P14784, P16871, P15336, Q16513, O00141 | PIK3CB, ERBB3, P2RY5, HSP90AA1, HSP90AB1, GNG5, GNG10, GNG11, ITGA6, CHAD, LAMB3, IFNAR2, IL2RB, IL7R, ATF2, PKN2, SGK | More | | Glutamic-acid | hsa04216 | Ferroptosis | 4.50E-02 | 1 | P48506 | GCLC | More | | Glutamic-acid | hsa04217 | Necroptosis | 1.93E-02 | 4 | P48551, P52630, P07384, Q99878 | IFNAR2, STAT2, CAPN1, H2AC14 | More | | Glutamic-acid | hsa04218 | Cellular senescence | 4.79E-02 | 4 | P01106, O75293, P30304, P06493 | MYC, GADD45B, CDC25A, CDK1 | More | | Glutamic-acid | hsa04340 | Hedgehog signaling pathway | 8.25E-04 | 6 | P49841, P22694, Q13635, O43791, P30279, P10415 | GSK3B, PRKACB, PTCH1, SPOP, CCND2, BCL2 | More | | Glutamic-acid | hsa04371 | Apelin signaling pathway | 7.45E-03 | 5 | P63218, P50151, Q13485, Q16566, P0DP23 | GNG5, GNG10, SMAD4, CAMK4, CALM1 | More | | Glutamic-acid | hsa04390 | Hippo signaling pathway | 2.00E-02 | 2 | P30279, P41134 | CCND2, ID1 | More | | Glutamic-acid | hsa04530 | Tight junction | 3.85E-02 | 3 | P60709, P63261, P60660 | ACTB, ACTG1, MYL6 | More | | Glutamic-acid | hsa04610 | Complement and coagulation cascades | 4.11E-08 | 3 | P00734, P0C0L4, P05107 | F2, C4A, ITGB2 | More | | Glutamic-acid | hsa04621 | NOD-like receptor signaling pathway | 7.28E-03 | 5 | P52630, P48551, P59665, P59666, Q16513 | STAT2, IFNAR2, DEFA1; DEFA1B, DEFA3, PKN2 | More | | Glutamic-acid | hsa04622 | RIG-I-like receptor signaling pathway | 1.36E-02 | 2 | Q12933, P10145 | TRAF2, IL8 | More | | Glutamic-acid | hsa04630 | JAK-STAT signaling pathway | 1.44E-02 | 4 | P52630, P48551, P16871, Q06124 | STAT2, IFNAR2, IL7R, PTPN11 | More | | Glutamic-acid | hsa04640 | Hematopoietic cell lineage | 9.13E-05 | 10 | P13612, P08514, P21926, P14778, P25063, P07766, P09693, P01730, P09564, P13765 | ITGA4, ITGA2B, CD9, IL1R1, CD24, CD3E, CD3G, CD4, CD7, HLA-DOB | More | | Glutamic-acid | hsa04658 | Th1 and Th2 cell differentiation | 1.01E-04 | 7 | P07766, P20963, P09693, P01730, P06239, Q9UL17, P13765 | CD3E, CD247, CD3G, CD4, LCK, TBX21, HLA-DOB | More | | Glutamic-acid | hsa04659 | Th17 cell differentiation | 4.70E-05 | 9 | Q16539, P01730, P06239, P13765, P14778, Q9UL17, P07766, P09693, P20963 | MAPK14, CD4, LCK, HLA-DOB, IL1R1, TBX21, CD3E, CD3G, CD247 | More | | Glutamic-acid | hsa04660 | T cell receptor signaling pathway | 1.18E-03 | 7 | O95267, Q08881, P07766, P20963, P09693, P01730, P06239 | RASGRP1, ITK, CD3E, CD247, CD3G, CD4, LCK | More | | Glutamic-acid | hsa04662 | B cell receptor signaling pathway | 2.37E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Glutamic-acid | hsa04664 | Fc epsilon RI signaling pathway | 2.32E-02 | 3 | P42338, P07948, P09917 | PIK3CB, LYN, ALOX5 | More | | Glutamic-acid | hsa04666 | Fc gamma R-mediated phagocytosis | 4.10E-02 | 3 | P07948, P42338, P23528 | LYN, PIK3CB, CFL1 | More | | Glutamic-acid | hsa04672 | Intestinal immune network for IgA production | 3.01E-02 | 2 | P13765, P13612 | HLA-DOB, ITGA4 | More | | Glutamic-acid | hsa04713 | Circadian entrainment | 5.49E-04 | 7 | O15399, P0DP23, Q13557, Q02153, P63218, P50151, P61952 | GRIN2D, CALM1, CAMK2D, GUCY1B3, GNG5, GNG10, GNG11 | More | | Glutamic-acid | hsa04714 | Thermogenesis | 2.84E-03 | 4 | P15336, P60709, P63261, P36542 | ATF2, ACTB, ACTG1, ATP5C1 | More | | Glutamic-acid | hsa04720 | Long-term potentiation | 1.63E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Glutamic-acid | hsa04724 | Glutamatergic synapse | 1.65E-03 | 6 | O15399, P43003, P63218, P50151, P61952, P15104 | GRIN2D, SLC1A3, GNG5, GNG10, GNG11, GLUL | More | | Glutamic-acid | hsa04725 | Cholinergic synapse | 4.23E-04 | 6 | P63218, P50151, P61952, Q16566, Q13557, P42338 | GNG5, GNG10, GNG11, CAMK4, CAMK2D, PIK3CB | More | | Glutamic-acid | hsa04726 | Serotonergic synapse | 1.52E-02 | 4 | P63218, P50151, P33260, P09917 | GNG5, GNG10, CYP2C18, ALOX5 | More | | Glutamic-acid | hsa04727 | GABAergic synapse | 1.54E-02 | 5 | P63218, P50151, P61952, P15104, Q15111 | GNG5, GNG10, GNG11, GLUL, PLCL1 | More | | Glutamic-acid | hsa04728 | Dopaminergic synapse | 5.26E-03 | 7 | P14416, P63218, P50151, P15336, P07101, P0DP23, O00327 | DRD2, GNG5, GNG10, ATF2, TH, CALM1, ARNTL | More | | Glutamic-acid | hsa04921 | Oxytocin signaling pathway | 2.81E-02 | 3 | P60660, P60709, P63261 | MYL6, ACTB, ACTG1 | More | | Glutamic-acid | hsa04924 | Renin secretion | 3.64E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Glutamic-acid | hsa04925 | Aldosterone synthesis and secretion | 3.14E-02 | 3 | P0DP23, Q16566, P23634 | CALM1, CAMK4, ATP2B4 | More | | Glutamic-acid | hsa04926 | Relaxin signaling pathway | 5.70E-03 | 5 | P42338, P63218, P50151, P49767, P30679 | PIK3CB, GNG5, GNG10, VEGFC, GNA15 | More | | Glutamic-acid | hsa04950 | Maturity onset diabetes of the young | 4.70E-02 | 1 | P35557 | GCK | More | | Glutamic-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Glutamic-acid | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Glutamic-acid | hsa05017 | Spinocerebellar ataxia | 5.94E-03 | 4 | Q8TB72, O15399, P42338, P21796 | PUM2, GRIN2D, PIK3CB, VDAC1 | More | | Glutamic-acid | hsa05030 | Cocaine addiction | 1.35E-03 | 3 | P14416, P07101, P15336 | DRD2, TH, ATF2 | More | | Glutamic-acid | hsa05034 | Alcoholism | 2.44E-03 | 9 | O15399, P07101, P15336, Q16566, P0DP23, P14416, P63218, P50151, Q99878 | GRIN2D, TH, ATF2, CAMK4, CALM1, DRD2, GNG5, GNG10, H2AC14 | More | | Glutamic-acid | hsa05100 | Bacterial invasion of epithelial cells | 2.44E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Glutamic-acid | hsa05110 | Vibrio cholerae infection | 2.44E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Glutamic-acid | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 6.89E-03 | 2 | Q99437, P10145 | ATP6V0B, IL8 | More | | Glutamic-acid | hsa05130 | Pathogenic Escherichia coli infection | 2.21E-02 | 4 | P60709, P63261, Q06124, O95487 | ACTB, ACTG1, PTPN11, SEC24B | More | | Glutamic-acid | hsa05133 | Pertussis | 8.35E-05 | 3 | P05107, P10145, P0C0L4 | ITGB2, IL8, C4A | More | | Glutamic-acid | hsa05134 | Legionellosis | 4.99E-03 | 2 | P11142, P19875 | HSPA8, CXCL2 | More | | Glutamic-acid | hsa05135 | Yersinia infection | 2.81E-02 | 3 | P60709, P63261, Q16513 | ACTB, ACTG1, PKN2 | More | | Glutamic-acid | hsa05143 | African trypanosomiasis | 4.21E-05 | 2 | P69905, P68871 | HBA2, HBB | More | | Glutamic-acid | hsa05144 | Malaria | 3.30E-05 | 8 | P69905, P68871, O60603, P01375, P05107, P35443, P10145, P26718 | HBA2, HBB, TLR2, TNF, ITGB2, THBS4, IL8, KLRK1 | More | | Glutamic-acid | hsa05146 | Amoebiasis | 3.24E-02 | 4 | P09341, P05089, P12814, P08311 | CXCL1, ARG1, ACTN1, CTSG | More | | Glutamic-acid | hsa05150 | Staphylococcus aureus infection | 3.50E-02 | 2 | P0C0L4, P05107 | C4A, ITGB2 | More | | Glutamic-acid | hsa05162 | Measles | 3.73E-02 | 2 | P11142, P30279 | HSPA8, CCND2 | More | | Glutamic-acid | hsa05163 | Human cytomegalovirus infection | 4.19E-02 | 5 | P42338, P63218, P50151, P0DP23, P30101 | PIK3CB, GNG5, GNG10, CALM1, PDIA3 | More | | Glutamic-acid | hsa05164 | Influenza A | 8.62E-03 | 4 | P48551, P52630, P60709, P63261 | IFNAR2, STAT2, ACTB, ACTG1 | More | | Glutamic-acid | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.19E-02 | 5 | P42338, P63218, P50151, P07948, P0DP23 | PIK3CB, GNG5, GNG10, LYN, CALM1 | More | | Glutamic-acid | hsa05169 | Epstein-Barr virus infection | 4.01E-02 | 6 | P13765, O00463, P24522, P07766, P09693, P20963 | HLA-DOB, TRAF5, GADD45A, CD3E, CD3G, CD247 | More | | Glutamic-acid | hsa05170 | Human immunodeficiency virus 1 infection | 3.30E-03 | 11 | P42338, P63218, P50151, P0DP23, O00463, P30101, P01730, P23528, P07766, P09693, P20963 | PIK3CB, GNG5, GNG10, CALM1, TRAF5, PDIA3, CD4, CFL1, CD3E, CD3G, CD247 | More | | Glutamic-acid | hsa05204 | Chemical carcinogenesis | 4.62E-02 | 2 | P78417, P33260 | GSTO1, CYP2C18 | More | | Glutamic-acid | hsa05214 | Glioma | 2.32E-02 | 3 | P0DP23, Q16566, P42338 | CALM1, CAMK4, PIK3CB | More | | Glutamic-acid | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | | Glutamic-acid | hsa05223 | Non-small cell lung cancer | 1.39E-02 | 3 | P10826, Q9HC35, O75293 | RARB, EML4, GADD45B | More | | Glutamic-acid | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.98E-05 | 7 | O95267, P07766, P20963, P09693, P06239, Q9HC35, P01730 | RASGRP1, CD3E, CD247, CD3G, LCK, EML4, CD4 | More | | Glutamic-acid | hsa05321 | Inflammatory bowel disease | 4.92E-02 | 4 | O60603, P01375, Q14765, Q9UL17 | TLR2, TNF, STAT4, TBX21 | More | | Glutamic-acid | hsa05323 | Rheumatoid arthritis | 4.28E-02 | 2 | Q99437, P10145 | ATP6V0B, IL8 | More | | Glutamic-acid | hsa05332 | Graft-versus-host disease | 1.80E-02 | 4 | P10747, P01375, P26715, Q13241 | CD28, TNF, KLRC1, KLRD1 | More | | Glutamic-acid | hsa05340 | Primary immunodeficiency | 6.61E-06 | 5 | P01730, P11912, Q8WV28, P07766, P06239 | CD4, CD79A, BLNK, CD3E, LCK | More | | Glutamic-acid | hsa05410 | Hypertrophic cardiomyopathy | 1.58E-03 | 5 | P23229, P26012, P09493, P60709, P63261 | ITGA6, ITGB8, TPM1, ACTB, ACTG1 | More | | Glutamic-acid | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 2.01E-03 | 4 | P54284, P23229, P60709, P63261 | CACNB3, ITGA6, ACTB, ACTG1 | More | | Glutamic-acid | hsa05414 | Dilated cardiomyopathy | 1.57E-02 | 3 | P23229, P60709, P63261 | ITGA6, ACTB, ACTG1 | More | | Glutamic-acid | hsa05416 | Viral myocarditis | 2.29E-03 | 3 | P30511, P60709, P63261 | HLA-F, ACTB, ACTG1 | More | | |